ChEMBL logo

ChEMBL

spacer
ChEMBL Statistics
  Loading Statistics...
spacer

Compound Report Card

Compound Name and Classification

Compound ID CHEMBL2107857
CHEMBL2107857
Compound Name METRELEPTIN
ChEMBL Synonyms METRELEPTIN | R-METHULEPTIN
Max Phase 4 (Approved)
Trade Names

Molecule Features

CHEMBL2107857 compound icon
Drug Type:Oligopeptide Rule of Five:N First In Class:Y Chirality:Single Stereoisomer Prodrug:N Oral:N Parenteral:Y Topical:N Black Box:Y Availability Type:Prescription-only

Mechanism of Action

Mechanism of Action ChEMBL Target References
Leptin receptor agonist Leptin receptor FDA

Indications

MESH Heading MESH ID EFO ID EFO Term Max phase for indication
DIABETES MELLITUS, TYPE 1D003922EFO:0001359TYPE I DIABETES MELLITUS1
HIV INFECTIONSD015658EFO:0000764HIV INFECTION2
NON-ALCOHOLIC FATTY LIVER DISEASED065626EFO:0003095NON-ALCOHOLIC FATTY LIVER DISEASE2
OBESITYD009765EFO:0001073OBESITY3

Clinical Data

Number of clinical trials registered at clinicaltrials.gov
Number of reviews at The Cochrane Collaboration
Number of entries at British National Formulary

Compound Cross References

ChemSpider ChemSpider Identifier not yet assigned
DailyMed metreleptin
spacer
spacer